Works matching AU Takeda, Masayuki


Results: 206
    1
    2

    Progression-Free and Overall Survival of Patients With ALK Rearrangement-Positive Non-Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib.

    Published in:
    2016
    By:
    • Satomi Watanabe;
    • Hidetoshi Hayashi;
    • Kunio Okamoto;
    • Kimiko Fujiwara;
    • Yoshikazu Hasegawa;
    • Hiroyasu Kaneda;
    • Kaoru Tanaka;
    • Masayuki Takeda;
    • Kazuhiko Nakagawa;
    • Watanabe, Satomi;
    • Hayashi, Hidetoshi;
    • Okamoto, Kunio;
    • Fujiwara, Kimiko;
    • Hasegawa, Yoshikazu;
    • Kaneda, Hiroyasu;
    • Tanaka, Kaoru;
    • Takeda, Masayuki;
    • Nakagawa, Kazuhiko
    Publication type:
    journal article
    3
    4
    5
    6
    7

    Balloon Dilatation for Entire Urethral Stricture.

    Published in:
    Urologia Internationalis, 1991, v. 46, n. 2, p. 232, doi. 10.1159/000282141
    By:
    • Nishiyama, Tsutomu;
    • Go, Hideto;
    • Takashima, Akio;
    • Kawakami, Yoshiaki;
    • Takeda, Masayuki;
    • Sato, Shotaro
    Publication type:
    Article
    8

    A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 376, doi. 10.1016/j.cllc.2020.12.009
    By:
    • Takeda, Masayuki;
    • Shimokawa, Mototsugu;
    • Nakamura, Atsushi;
    • Nosaki, Kaname;
    • Watanabe, Yasutaka;
    • Kato, Terufumi;
    • Hayakawa, Daisuke;
    • Tanaka, Hiroshi;
    • Takahashi, Toshiaki;
    • Kogure, Yoshihito;
    • Tachihara, Motoko;
    • Fujimoto, Daichi;
    • Yamaguchi, Kakuhiro;
    • Hamaguchi, Naohiko;
    • Okamoto, Isamu;
    • Azuma, Koichi;
    • Hasegawa, Kazuo;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    9
    10
    11

    Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.

    Published in:
    Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13941
    By:
    • YOSHIHIKO FUJITA;
    • HIROMICHI MATSUOKA;
    • YASUTAKA CHIBA;
    • JUNJI TSURUTANI;
    • TAKESHI YOSHIDA;
    • KIYOHIRO SAKAI;
    • MIKI NAKURA;
    • RYO SAKAMOTO;
    • CHIHIRO MAKIMURA;
    • YOICHI OHTAKE;
    • KAORU TANAKA;
    • HIDETOSHI HAYASHI;
    • MASAYUKI TAKEDA;
    • TATSUYA OKUNO;
    • NAOKI TAKEGAWA;
    • KOJI HARATANI;
    • TAKAYUKI TAKAHAMA;
    • JUNKO TANIZAKI;
    • ATSUKO KOYAMA;
    • KAZUTO NISHIO
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE).

    Published in:
    Oncology & Therapy, 2022, v. 10, n. 1, p. 253, doi. 10.1007/s40487-022-00188-2
    By:
    • Hata, Akito;
    • Shiraishi, Yoshimasa;
    • Inui, Naoki;
    • Okada, Morihito;
    • Morise, Masahiro;
    • Akiyoshi, Kohei;
    • Takeda, Masayuki;
    • Watanabe, Yasutaka;
    • Sugawara, Shunichi;
    • Shinagawa, Naofumi;
    • Kubota, Kaoru;
    • Saeki, Toshiaki;
    • Tamura, Tomohide
    Publication type:
    Article
    24
    25

    Effects of fatty acid metabolites on nocturia.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07096-5
    By:
    • Ihara, Tatsuya;
    • Shimura, Hiroshi;
    • Tsuchiya, Sachiko;
    • Kanda, Mie;
    • Kira, Satoru;
    • Sawada, Norifumi;
    • Takeda, Masayuki;
    • Mitsui, Takahiko;
    • Shigetomi, Eiji;
    • Shinozaki, Yoichi;
    • Koizumi, Schuichi
    Publication type:
    Article
    26
    27
    28
    29

    Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial.

    Published in:
    2016
    By:
    • Takeda, Masayuki;
    • Yamanaka, Takeharu;
    • Seto, Takashi;
    • Hayashi, Hidetoshi;
    • Azuma, Koichi;
    • Okada, Morihito;
    • Sugawara, Shunichi;
    • Daga, Haruko;
    • Hirashima, Tomonori;
    • Yonesaka, Kimio;
    • Urata, Yoshiko;
    • Murakami, Haruyasu;
    • Saito, Haruhiro;
    • Kubo, Akihito;
    • Sawa, Toshiyuki;
    • Miyahara, Eiji;
    • Nogami, Naoyuki;
    • Nakagawa, Kazuhiko;
    • Nakanishi, Yoichi;
    • Okamoto, Isamu
    Publication type:
    journal article
    30

    Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 12, p. 2275, doi. 10.1002/cncr.28048
    By:
    • Urata, Yoshiko;
    • Okamoto, Isamu;
    • Takeda, Masayuki;
    • Hattori, Yoshihiro;
    • Okuno, Keiko;
    • Shimada, Temiko;
    • Kurata, Takayasu;
    • Kaneda, Hiroyasu;
    • Miyazaki, Masaki;
    • Terashima, Masaaki;
    • Tanaka, Kaoru;
    • Morita, Satoshi;
    • Nakagawa, Kazuhiko;
    • Negoro, Shunichi;
    • Satouchi, Miyako
    Publication type:
    Article
    31
    32
    33
    34

    Application of linear and machine learning models to genomic prediction of fatty acid composition in Japanese Black cattle.

    Published in:
    Animal Science Journal, 2023, v. 94, n. 1, p. 1, doi. 10.1111/asj.13883
    By:
    • Nishio, Motohide;
    • Inoue, Keiichi;
    • Arakawa, Aisaku;
    • Ichinoseki, Kasumi;
    • Kobayashi, Eiji;
    • Okamura, Toshihiro;
    • Fukuzawa, Yo;
    • Ogawa, Shinichiro;
    • Taniguchi, Masaaki;
    • Oe, Mika;
    • Takeda, Masayuki;
    • Kamata, Takehiro;
    • Konno, Masaru;
    • Takagi, Michihiro;
    • Sekiya, Mario;
    • Matsuzawa, Tamotsu;
    • Inoue, Yoshinobu;
    • Watanabe, Akihiro;
    • Kobayashi, Hiroshi;
    • Shibata, Eri
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Safety and efficacy of mirabegron as 'add-on' therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan ( MILAI study).

    Published in:
    BJU International, 2015, v. 116, n. 4, p. 612, doi. 10.1111/bju.13068
    By:
    • Yamaguchi, Osamu;
    • Kakizaki, Hidehiro;
    • Homma, Yukio;
    • Igawa, Yasuhiko;
    • Takeda, Masayuki;
    • Nishizawa, Osamu;
    • Gotoh, Momokazu;
    • Yoshida, Masaki;
    • Yokoyama, Osamu;
    • Seki, Narihito;
    • Okitsu, Akira;
    • Hamada, Takuya;
    • Kobayashi, Akiko;
    • Kuroishi, Kentarou
    Publication type:
    Article
    46
    47

    Predictive factors for the effect of the α1-D/A adrenoceptor antagonist naftopidil on subjective and objective criteria in patients with neurogenic lower urinary tract dysfunction.

    Published in:
    BJU International, 2011, v. 108, n. 1, p. 100, doi. 10.1111/j.1464-410X.2010.09682.x
    By:
    • Takeda, Masayuki;
    • Homma, Yukio;
    • Araki, Isao;
    • Kakizaki, Hidehiro;
    • Yamanishi, Tomonori;
    • Yokota, Takashi;
    • Gotoh, Momokazu;
    • Igawa, Yasuhiko;
    • Seki, Narihito;
    • Takei, Mineo;
    • Yoshida, Masaki;
    • Sugaya, Kimio;
    • Nishizawa, Osamu
    Publication type:
    Article
    48
    49
    50

    REACHABILITY ON SUFFIX TREE GRAPHS.

    Published in:
    International Journal of Foundations of Computer Science, 2008, v. 19, n. 1, p. 147, doi. 10.1142/S0129054108005590
    By:
    • HIGA, YASUTO;
    • BANNAI, HIDEO;
    • INENAGA, SHUNSUKE;
    • TAKEDA, MASAYUKI
    Publication type:
    Article